Africa’s Progress Towards Eliminating Neglected Tropical Diseases
As Africa continues its fight against neglected tropical diseases (NTDs), significant strides have been made in uniting countries and organizations under the Kigali Declaration. Launched by Rwanda’s President Paul Kagame, the declaration, now celebrating its third anniversary on June 23, 2025, has garnered support from over 80 signatories, with a focus on eradicating NTDs by the year 2030.
A Collective Effort for Improved Health
NTDs impact more than one billion individuals globally, with Africa bearing nearly 40% of the burden. Conditions such as trachoma and lymphatic filariasis not only compromise health but also impede access to education and economic opportunities. The Kigali Declaration has seen an increase in signatories from 57 in 2022 to 84, with Sudan being the latest country to pledge its commitment. This growing coalition underscores Africa’s resolve to combat NTDs and alleviate the suffering they cause.
Dr. Isatou Touray, Executive Director of Uniting to Combat Neglected Tropical Diseases, underscores the importance of ongoing efforts: “Each endorsement brings us closer to eliminating diseases that have a profound impact on lives. Consistent action is crucial in achieving our 2030 target.”
Tangible Progress and Industry Support
The Kigali Declaration has already yielded positive outcomes. Leading pharmaceutical companies like Merck, GSK, and Novartis have pledged 28 billion units of medication through 2030, with notable milestones such as Merck’s administration of the five billionth dose of Mectizan and GSK’s distribution of the 12 billionth dose of albendazole. Additionally, the European and Developing Countries Clinical Trials Partnership has allocated a €46 million fund for NTD research in 2025, fostering innovation in the field.
Accountability is maintained through transparency. The Kigali Declaration Commitment Tracker, an innovative online tool, enables stakeholders to track funding and progress, ensuring that resources reach those most in need.
Overcoming Challenges in the Path to Success
Despite the progress made, potential cuts in global funding pose a significant threat to ongoing efforts. Reductions in official development assistance, particularly from major donors like the United States, could result in over one million donated medications expiring within nine months. This scenario risks leaving millions untreated, jeopardizing the progress achieved thus far.
Nevertheless, Africa’s resilience is evident. Mauritania recently celebrated the elimination of trachoma, joining 55 other countries that have successfully eradicated at least one NTD. Since early 2024, eleven nations have achieved this milestone, demonstrating the effectiveness of sustained investments.
A Call to Action for Continued Progress
With the momentum of the Kigali Declaration building, the global health community faces a critical juncture. Innovative financing mechanisms and renewed dedication are essential to safeguard vulnerable populations and uphold Africa’s positive trajectory. Through continued collaboration, the continent stands poised to transform lives and redefine the narrative surrounding NTDs.
